Therapeutic effect and safety of Wei-Fu-Chun in the treatment of chronic atrophic gastritis: a network meta-analysis.

ABSTRACT:

Introduction

Chronic atrophic gastritis (CAG) is a chronic condition characterized by a reduction in gastric mucosal glands and is often regarded as a precursor to gastric cancer. Currently, Western medicine lacks specific treatments for CAG, with management primarily focusing on symptomatic relief and, in cases involving Helicobacter pylori infection, eradication therapy. This study employs a network meta-analysis (NMA) to evaluate the efficacy and safety of the Chinese patent medicine Wei-Fu-Chun (WFC) in the treatment of CAG.

Methods

We systematically reviewed randomized controlled trials (RCTs) comparing WFC with other interventions for CAG. The outcomes assessed included clinical effectiveness, gastrointestinal symptom scores, gastrointestinal hormone levels, and

SUBMITTER: Wu Y 

PROVIDER: S-EPMC12676455 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature